Positively Sharing

U.S. FDA approves GSK’s HIV drug for patients with limited options

Reading Time: < 1 minute

The U.S. Food and Drug Administration on Thursday approved GlaxoSmithKline Plc’s HIV drug, Rukobia, to treat adult patients, Read More

Exit mobile version